Astex – Oncology and CNS Drug Discovery & Development

Committed to the fight against cancer and CNS disorders

Committed to the fight against cancer and CNS disorders

World leading innovative drug discovery & development

Our research and development teams utilize our cutting edge technology platform in the relentless pursuit of innovative solutions that address the extensive and complex challenges in oncology and diseases of the CNS.

Astex has built a rich product portfolio with multiple drugs in clinical development

Latest from Astex

20 November 2023

Third Success from Astex Drug Discovery Pharma Collaboration and Licence Agreements as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)

17 November 2023

Taiho Oncology and Astex Pharmaceuticals Announce Data Presentations at the 65th ASH Annual Meeting

In the News

December 2023
Interview with Harren Jhoti: How Astex built a business based on fragment-based drug discovery

17 November 2023
Third Success from Astex Drug Discovery Pharma Collaborations as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib)

08 August 2023
Merck enlists Astex to search for p53 cancer drug in expanded deal

Sustaining Innovation

Sustaining Innovation Postdoctoral Training Program

Career Opportunities

We seek to attract and retain talented individuals who are passionate about improving patient outcomes.

icon_Interactive_White

Interactive Scientific Resources

Explore 3D protein-ligand structures from recent Astex publications.

Download software developed by Astex scientists.